Chemoinformaics analysis of 1-Dehydrotrillenogenin
| Molecular Weight | 474.55 | nRot | 1 |
| Heavy Atom Molecular Weight | 440.278 | nRig | 32 |
| Exact Molecular Weight | 474.225 | nRing | 6 |
| Solubility: LogS | -3.635 | nHRing | 2 |
| Solubility: LogP | 0.945 | No. of Aliphatic Rings | 6 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 68 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 26 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 0 |
| nHA | 8 | APOL | 72.507 |
| nHD | 4 | BPOL | 39.317 |
| QED | 0.412 |
| Synth | 6.136 |
| Natural Product Likeliness | 2.634 |
| NR-PPAR-gamma | 0.253 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.085 |
| HIA | 0.795 |
| CACO-2 | -5.104 |
| MDCK | 0.000148715 |
| BBB | 0.891 |
| PPB | 0.782006 |
| VDSS | 0.916 |
| FU | 0.137136 |
| CYP1A2-inh | 0.005 |
| CYP1A2-sub | 0.323 |
| CYP2c19-inh | 0.007 |
| CYP2c19-sub | 0.632 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.057 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.073 |
| CYP3a4-inh | 0.164 |
| CYP3a4-sub | 0.632 |
| CL | 6.161 |
| T12 | 0.056 |
| hERG | 0.008 |
| Ames | 0.018 |
| ROA | 0.99 |
| SkinSen | 0.014 |
| Carcinogencity | 0.765 |
| EI | 0.005 |
| Respiratory | 0.967 |
| NR-Aromatase | 0.039 |
| Antiviral | Yes |
| Prediction | 0.757895 |